Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Reolysin enters phase I/II in brain cancer

July 5, 2002

Gleevec submitted in U.S. and E.U. for first-line use in CML

July 5, 2002

Heat-activated drug therapy for prostate cancer enters clinical trials

July 5, 2002

Antisoma's vascular targeting agent well tolerated in phase I trials

July 5, 2002

Inhibitors of ubiquitin ligases as potential new anticancer agents

July 5, 2002

Advexin lung cancer patient reaches five-year survival

July 4, 2002

Highly potent prodrug for use in ADEPT of cancer

July 4, 2002

Melanoma vaccine candidate based on bacterial adjuvant protein and MART-1-derived peptide

July 4, 2002

Phase III trials in preparation for Cotara in advanced brain cancer

July 4, 2002

NeoPharm submits IND for LE-SN-38

July 3, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...